Literature DB >> 17568647

E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.

Mariam Mansour1, Majid Touka, Uzma Hasan, Angelica Bellopede, Anouk Smet, Rosita Accardi, Anne-Sophie Gabet, Bakary S Sylla, Massimo Tommasino.   

Abstract

Epidemiological studies have demonstrated that 15 different mucosal human papillomavirus (HPV) types of the genus alpha of the HPV phylogetic tree are classified as high risk for cervical cancer development. Three additional HPV types of the same genus, HPV26, 53 and 66, are classified as probable high-risk types. In this study, we have characterized the biological properties of the E7 oncoproteins from these three HPV types. All of the corresponding E7 proteins were able to associate with retinoblastoma protein (pRb) and up-regulated the expression of several positive cell cycle regulators, i.e. CDK2, cyclin A and cylin E. However, HPV26 E7 appears to be more efficient than HPV53 and 66 E7 in up-regulating the transcription of cyclin A. Unlike E7 from the high-risk type HPV16 protein, HPV26, 53 and 66 did not efficiently promote pRb degradation. In addition, E7 from these viruses was able to promote proliferation of primary human keratinocytes and circumvent G1 arrest imposed by overexpression of p16(INK4a), but with less efficiency than the high-risk HPV16 E7. Together, our data show that in vitro properties of these E7 proteins correlate with the epidemiological classification of HPV26, 53 and 66 as HPV types with an intermediate risk for cervical cancer development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568647     DOI: 10.1016/j.virol.2007.05.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

2.  The human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.

Authors:  Weifang Zhang; Jing Li; Sriramana Kanginakudru; Weiming Zhao; Xiuping Yu; Jason J Chen
Journal:  Virology       Date:  2009-11-27       Impact factor: 3.616

3.  Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.

Authors:  Yunying Zhou; Qishu Zhang; Ge Gao; Xiaoli Zhang; Yafei Liu; Shoudao Yuan; Xiaowei Wang; Jason J Chen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

4.  The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter.

Authors:  Uzma A Hasan; Claudia Zannetti; Peggy Parroche; Nadège Goutagny; Marine Malfroy; Guillaume Roblot; Christine Carreira; Ishraq Hussain; Martin Müller; Joyce Taylor-Papadimitriou; Didier Picard; Bakary S Sylla; Giorgio Trinchieri; Ruslan Medzhitov; Massimo Tommasino
Journal:  J Exp Med       Date:  2013-06-10       Impact factor: 14.307

5.  TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression.

Authors:  P Parroche; G Roblot; F Le Calvez-Kelm; I Tout; M Marotel; M Malfroy; G Durand; J McKay; M Ainouze; C Carreira; O Allatif; A Traverse-Glehen; M Mendiola; J J Pozo-Kreilinger; C Caux; M Tommasino; N Goutagny; U A Hasan
Journal:  Oncogenesis       Date:  2016-07-25       Impact factor: 7.485

6.  Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β.

Authors:  Michelle Ainouze; Pauline Rochefort; Peggy Parroche; Guillaume Roblot; Issam Tout; François Briat; Claudia Zannetti; Marie Marotel; Nadege Goutagny; Philip Auron; Alexandra Traverse-Glehen; Aude Lunel-Potencier; Francois Golfier; Murielle Masson; Alexis Robitaille; Massimo Tommasino; Christine Carreira; Thierry Walzer; Thomas Henry; Katia Zanier; Gilles Trave; Uzma Ayesha Hasan
Journal:  PLoS Pathog       Date:  2018-08-08       Impact factor: 6.823

7.  Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study.

Authors:  Shalaka S Hampras; Anna R Giuliano; Hui-Yi Lin; Kate J Fisher; Martha E Abrahamsen; Bradley A Sirak; Michelle R Iannacone; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.